ProfileGDS4095 / 220752_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 32% 7% 24% 11% 13% 15% 15% 15% 13% 22% 19% 9% 17% 10% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.4173632
GSM709769LY2 SRC1-siRNA tamoxifen treated rep31.648617
GSM709765LY2 SRC1-siRNA untreated rep32.1572624
GSM709771LY2 SRC1-siRNA untreated rep11.7917811
GSM709772LY2 SRC1-siRNA untreated rep21.8499513
GSM709775LY2 SRC1-siRNA untreated rep41.9260515
GSM709764LY2 control-siRNA tamoxifen treated rep21.8974215
GSM709766LY2 control-siRNA tamoxifen treated rep31.9172115
GSM709768LY2 control-siRNA tamoxifen treated rep11.8287513
GSM709777LY2 control-siRNA tamoxifen treated rep42.0952422
GSM709770LY2 control-siRNA untreated rep31.9907319
GSM709773LY2 control-siRNA untreated rep11.73249
GSM709774LY2 control-siRNA untreated rep21.9563317
GSM709776LY2 control-siRNA untreated rep41.7637910